Epigenetics refers to changes in gene expression or cellular phenotypes that are not due to changes in the underlying DNA sequence. Various techniques including histone modification, DNA methylation and chromatin modelling are used in epigenetics. Growing prevalence of chronic diseases such as cancer is driving the demand for epigenetic techniques to understand cancer biology and gene regulation. The epigenetics market provides products such as reagents, kits and assays which help to analyse epigenetic modifications and their effects on gene expression and functionality.

The Global Epigenetics Market is estimated to be valued at US$ 17.05 Bn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the epigenetics are L€TMOreal S.A, Procter and Gamble Company (P&G), Estee Lauder Companies Inc., The Unilever Plc, Shiseido Co. Ltd., Johnson and Johnson Limited, Kose Corporation, and Kao Corporation.

Key players operating in the epigenetics are focusing on launching innovative product offerings and enhancing their research capabilities. For instance, L€TMOreal S.A launched a new gene expression analysis service to enable researchers to study gene regulation in skin aging and diseases.

The demand for epigenetics techniques is growing significantly owing to increasing prevalence of cancer globally. Epigenetics help in tumor classification, biomarker discovery and risk assessment for cancer. According to WHO, cancer burden is expected to grow to 27 million new cases per year by 2040.

Technological advancements are expanding the scope of Global epigenetics market size applications. Next generation sequencing and microarray techniques are being integrated with epigenetic methods to identify epigenetic modifications involved in diseases. This is supporting drug discovery and development efforts for various chronic conditions.

Market Trends

Increased funding for epigenetics research: Rising burden of diseases has boosted investments in epigenetics with focus on identifying gene regulation mechanisms. This is a key factor driving the adoption of technologically advanced epigenetic analysis products.

Integration of epigenetics with AI and machine learning: Leading players are leveraging AI, machine learning and big data analytics to develop precision medicine based on epigenetic modifications and disease risk stratification models. This emerging trend is expected to transform healthcare significantly.

Market Opportunities

Non-invasive biofluid analysis: Epigenetic testing of biofluids like blood and urine offers non-invasive alternatives to tissue samples. This increases accessibility and adoption of epigenetic techniques especially for population-wide screening programs.

Personalized medicine: Understanding epigenetic changes involved in an individual’s response to drugs, environment and lifestyle presents an opportunity to develop personalized clinically-relevant diagnostics, treatments and prevention strategies.

Impact of COVID-19 on Epigenetics Market
The COVID-19 pandemic has adversely impacted the growth of the epigenetics market. During the initial lockdown phases in various countries, most laboratories closed down leading to delays in ongoing epigenetics research projects. the supply chains were disrupted causing shortages of crucial epigenetic reagents and consumables. Many research collaborations and partnerships were stalled impacting innovation. However, with greater focus on finding novel treatments and vaccines for COVID-19, funding for epigenetics research increased in 2020 and 2021. Epigenetic mechanisms are being studied for their role in viral infections and associated inflammatory responses. Many ongoing clinical trials on using epigenetic drugs for conditions like cancer adopted virtual modes to continue patient enrollment and monitoring. With economies gradually opening up and restrictions easing, the market is recovering gradually in 2022.

Geographical Regions for Epigenetics Market

North America currently represents the largest regional market for epigenetics, accounting for over 40% of the global revenues. This is attributed to presence of major industry players, huge biotech industry, and increased funding for omics based research from governments as well as private entities in the US and Canada. Asia Pacific is poised to be the fastest growing regional market owing to rising healthcare expenditures, increasing public-private investments in life science infrastructure and presence of large patient pools in countries like China and India making them ideal locations for clinical trials. Government initiatives to promote local manufacturing are further strengthening the regional market. Europe is another major regional market driven by presence of leading academic research institutes and CROs focusing on translating epigenetics discoveries into clinical applications.

Geographical Regions with Fastest Growth for Epigenetics Market

Asia Pacific region is witnessing the fastest growth in the epigenetics market and is projected to surpass North America by 2028. This is attributable to rapid economic development in Asia Pacific countries outpacing global averages. Factors like rising per capita incomes, young demographic profile with higher incidence of chronic diseases, increasing awareness about personalized medicine and focus of biotech companies to tap into the huge patient populations are driving strong market growth. Governments of India, China, South Korea and Singapore are undertaking key initiatives to promote development of bioscience infrastructure and provide funding support. Presence of low-cost yet high-quality clinical research facilities is attracting outsourcing of epigenetics projects from multinational companies to the region. Local companies are also enhancing their R&D capabilities to develop novel epigenetics based solutions.

Get More Insights On This Topic: https://www.pressreleasebulletin.com/epigenetics-market-forecast-outlook-trend-2023-2030/